Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial.
Garcia-Manero G, Mufti GJ, Fenaux P, Buckstein R, Santini V, Díez-Campelo M, Finelli C, Ilhan O, Sekeres MA, Zeidan AM, Ito R, Zhang J, Rampersad A, Sinsimer D, Backstrom JT, Platzbecker U, Komrokji RS.
Garcia-Manero G, et al. Among authors: finelli c.
Blood. 2022 Jan 27;139(4):624-629. doi: 10.1182/blood.2021012589.
Blood. 2022.
PMID: 34758066
Free PMC article.
Clinical Trial.
No abstract available.